The Africa Diseases Prevention and Research Development Initiative (ADRAP) and its partners have unveiled their first disease training fellowship for African journalists to boost reportage of health-related issues.
Director, Learning and Development of ADRAP, Sarah Yusuf announced the development in a statement issued by its Chief Executive Officer, Dr. Joseph Enegela on Thursday, December 7, 2023.
Yusuf stated that the Africa Diseases Reporting Fellowship (ADRF) aimed to elevate the quality of health reports in the continent.
She quoted Enegela as saying, “this ground-breaking initiative aims to empower journalists across the African continent to report accurately and effectively on critical health issues.
“The six-week hybrid programme will consist of virtual and in-person contacts with experts in the field of health and journalism.
“Topics to be covered include Foundations of Health Journalism, Health Literacy, Research and Disease Reporting, Contextual Reporting of Epidemics and Pandemics in Africa.
“Others are Reporting Emerging Infectious and Non-Communicable Diseases with a focus on Ebola and Post-Partum Haemorrhage and Data in Disease Reporting.”
Enegela said the training would equip journalists and bloggers with the knowledge and resources necessary to address critical health issues in the region.
He added that fellows would also be exposed to advances in multimedia and storytelling and ethical use of Artificial Intelligence in journalism, as well as learn from the experiences of other participants.
He advised interested applicants to apply using the designated portal and that the application will close at the end of December.
ADRAP is a non-government organisation incorporated in Nigeria with the aim of creating and sustaining a world-class institution that supports the implementation of topical and outcomes-driven human diseases research.
It also supports health care system intervention and continuous medical education, as well as the use of innovative learning techniques to continually impart knowledge.